| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 13 | 2023 | 763 | 2.670 |
Why?
|
| Hypertension | 27 | 2021 | 1275 | 2.400 |
Why?
|
| Antihypertensive Agents | 13 | 2021 | 392 | 1.750 |
Why?
|
| Primary Health Care | 15 | 2017 | 748 | 1.680 |
Why?
|
| Cognition Disorders | 6 | 2019 | 555 | 1.170 |
Why?
|
| Cognition | 8 | 2024 | 734 | 1.030 |
Why?
|
| Cognitive Dysfunction | 5 | 2024 | 223 | 0.840 |
Why?
|
| Neuropsychological Tests | 8 | 2024 | 923 | 0.800 |
Why?
|
| Computer Communication Networks | 1 | 2022 | 15 | 0.790 |
Why?
|
| International Cooperation | 1 | 2022 | 160 | 0.740 |
Why?
|
| Blood Pressure | 8 | 2021 | 1317 | 0.730 |
Why?
|
| Medication Adherence | 4 | 2021 | 385 | 0.640 |
Why?
|
| Disease Progression | 4 | 2021 | 1996 | 0.630 |
Why?
|
| Caregivers | 1 | 2023 | 563 | 0.610 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 1033 | 0.610 |
Why?
|
| Aged | 33 | 2024 | 18917 | 0.560 |
Why?
|
| Patient Compliance | 5 | 2014 | 465 | 0.500 |
Why?
|
| Dementia | 4 | 2022 | 447 | 0.500 |
Why?
|
| Drug Resistance | 2 | 2014 | 257 | 0.470 |
Why?
|
| Vestibular Function Tests | 1 | 2014 | 34 | 0.470 |
Why?
|
| Office Visits | 1 | 2014 | 75 | 0.450 |
Why?
|
| Middle Aged | 41 | 2024 | 25798 | 0.450 |
Why?
|
| Community Networks | 1 | 2013 | 33 | 0.440 |
Why?
|
| Patient Education as Topic | 4 | 2016 | 439 | 0.440 |
Why?
|
| Vestibular Diseases | 1 | 2014 | 67 | 0.430 |
Why?
|
| Cyclobutanes | 1 | 2013 | 5 | 0.430 |
Why?
|
| Mental Recall | 1 | 2014 | 138 | 0.430 |
Why?
|
| Appetite Depressants | 1 | 2013 | 20 | 0.430 |
Why?
|
| Health Services Research | 2 | 2013 | 186 | 0.410 |
Why?
|
| Ceramides | 1 | 2012 | 38 | 0.400 |
Why?
|
| Humans | 72 | 2024 | 122853 | 0.400 |
Why?
|
| Delivery of Health Care | 3 | 2016 | 606 | 0.390 |
Why?
|
| Weight Loss | 2 | 2013 | 443 | 0.380 |
Why?
|
| Male | 54 | 2024 | 59866 | 0.380 |
Why?
|
| Female | 52 | 2024 | 65278 | 0.350 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 473 | 0.350 |
Why?
|
| Vitamin E | 1 | 2009 | 64 | 0.340 |
Why?
|
| Electronic Health Records | 3 | 2016 | 697 | 0.320 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 2 | 2022 | 11 | 0.320 |
Why?
|
| Education | 2 | 2006 | 105 | 0.320 |
Why?
|
| Elder Abuse | 4 | 2002 | 24 | 0.320 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 6325 | 0.320 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 263 | 0.310 |
Why?
|
| Vaccination | 4 | 2017 | 949 | 0.310 |
Why?
|
| Adult | 32 | 2018 | 28926 | 0.310 |
Why?
|
| Texas | 16 | 2016 | 3542 | 0.300 |
Why?
|
| Insulin | 2 | 2013 | 1196 | 0.300 |
Why?
|
| Biomarkers | 4 | 2024 | 2947 | 0.300 |
Why?
|
| Cohort Studies | 5 | 2024 | 4673 | 0.300 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 1834 | 0.280 |
Why?
|
| Antioxidants | 1 | 2009 | 341 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2006 | 1216 | 0.280 |
Why?
|
| Intelligence Tests | 1 | 2006 | 57 | 0.270 |
Why?
|
| Immunization Programs | 2 | 2017 | 63 | 0.270 |
Why?
|
| Physicians | 2 | 2011 | 583 | 0.260 |
Why?
|
| Intelligence | 1 | 2006 | 98 | 0.260 |
Why?
|
| Obesity | 4 | 2013 | 2089 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3479 | 0.250 |
Why?
|
| Patient Participation | 1 | 2007 | 218 | 0.250 |
Why?
|
| Decision Support Techniques | 1 | 2007 | 279 | 0.240 |
Why?
|
| Amnesia | 1 | 2024 | 20 | 0.230 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 639 | 0.220 |
Why?
|
| Parietal Lobe | 1 | 2024 | 41 | 0.220 |
Why?
|
| Markov Chains | 1 | 2023 | 80 | 0.220 |
Why?
|
| Health Promotion | 2 | 2016 | 385 | 0.220 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 289 | 0.210 |
Why?
|
| Chest Pain | 1 | 2004 | 125 | 0.210 |
Why?
|
| Mood Disorders | 1 | 2004 | 123 | 0.210 |
Why?
|
| Exercise Test | 1 | 2004 | 248 | 0.210 |
Why?
|
| Cohort Effect | 2 | 2019 | 5 | 0.210 |
Why?
|
| Databases, Factual | 3 | 2011 | 1163 | 0.200 |
Why?
|
| Life Style | 5 | 2023 | 397 | 0.190 |
Why?
|
| Neuroimaging | 1 | 2024 | 332 | 0.190 |
Why?
|
| Observational Studies as Topic | 1 | 2022 | 78 | 0.190 |
Why?
|
| Mortality | 1 | 2003 | 225 | 0.190 |
Why?
|
| Self Efficacy | 2 | 2013 | 191 | 0.190 |
Why?
|
| Physician's Role | 1 | 2003 | 164 | 0.190 |
Why?
|
| Blood Pressure Determination | 4 | 2011 | 105 | 0.190 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1290 | 0.190 |
Why?
|
| Health Services for the Aged | 1 | 2001 | 38 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 1246 | 0.180 |
Why?
|
| Risk Factors | 15 | 2014 | 9928 | 0.180 |
Why?
|
| Influenza, Human | 2 | 2017 | 647 | 0.180 |
Why?
|
| Cerebellum | 1 | 2024 | 414 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2007 | 1518 | 0.170 |
Why?
|
| Regression Analysis | 5 | 2016 | 756 | 0.170 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 2094 | 0.160 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 174 | 0.160 |
Why?
|
| Health Surveys | 3 | 2013 | 236 | 0.160 |
Why?
|
| Health Behavior | 3 | 2012 | 378 | 0.160 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 268 | 0.150 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 3 | 2013 | 51 | 0.150 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 425 | 0.150 |
Why?
|
| Mass Screening | 3 | 2014 | 786 | 0.150 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1999 | 153 | 0.150 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2018 | 96 | 0.150 |
Why?
|
| Network Meta-Analysis | 1 | 2017 | 37 | 0.140 |
Why?
|
| Anxiety | 1 | 2023 | 952 | 0.140 |
Why?
|
| Diphtheria-Tetanus Vaccine | 1 | 2016 | 3 | 0.140 |
Why?
|
| United States | 10 | 2021 | 10538 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2016 | 710 | 0.140 |
Why?
|
| Evidence-Based Medicine | 1 | 2000 | 611 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 743 | 0.130 |
Why?
|
| Linear Models | 3 | 2011 | 658 | 0.130 |
Why?
|
| Telephone | 1 | 1996 | 109 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 2 | 2007 | 228 | 0.130 |
Why?
|
| Brain | 2 | 2024 | 2961 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 108 | 0.130 |
Why?
|
| Immunization | 1 | 2017 | 308 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2014 | 1168 | 0.120 |
Why?
|
| Logistic Models | 5 | 2004 | 1777 | 0.120 |
Why?
|
| Pneumococcal Vaccines | 1 | 2016 | 168 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 359 | 0.120 |
Why?
|
| New York | 1 | 2015 | 66 | 0.120 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 5017 | 0.120 |
Why?
|
| Dizziness | 1 | 2014 | 27 | 0.120 |
Why?
|
| Prevalence | 6 | 2004 | 2384 | 0.110 |
Why?
|
| Minority Groups | 3 | 1993 | 251 | 0.110 |
Why?
|
| Activities of Daily Living | 3 | 2022 | 397 | 0.110 |
Why?
|
| Education, Medical | 2 | 2003 | 285 | 0.110 |
Why?
|
| White Coat Hypertension | 1 | 2013 | 10 | 0.110 |
Why?
|
| Physical Examination | 1 | 2014 | 163 | 0.110 |
Why?
|
| Education, Premedical | 2 | 1991 | 2 | 0.110 |
Why?
|
| Alcoholics Anonymous | 1 | 2013 | 3 | 0.110 |
Why?
|
| Temperance | 1 | 2013 | 15 | 0.110 |
Why?
|
| Self-Help Groups | 1 | 2013 | 17 | 0.110 |
Why?
|
| Diabetes Mellitus | 3 | 2013 | 846 | 0.110 |
Why?
|
| Postural Balance | 1 | 2014 | 125 | 0.110 |
Why?
|
| Religion and Medicine | 1 | 2013 | 24 | 0.110 |
Why?
|
| Health Literacy | 1 | 2014 | 79 | 0.110 |
Why?
|
| Biostatistics | 1 | 2012 | 10 | 0.100 |
Why?
|
| Motivation | 3 | 2016 | 312 | 0.100 |
Why?
|
| Spirituality | 1 | 2013 | 47 | 0.100 |
Why?
|
| Patient Selection | 1 | 1996 | 683 | 0.100 |
Why?
|
| Systole | 3 | 2011 | 197 | 0.100 |
Why?
|
| Smoking Cessation | 2 | 2012 | 194 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 218 | 0.100 |
Why?
|
| Young Adult | 3 | 2018 | 8826 | 0.100 |
Why?
|
| Referral and Consultation | 2 | 2014 | 527 | 0.100 |
Why?
|
| Exercise | 4 | 2023 | 790 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 470 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 791 | 0.100 |
Why?
|
| Internal Medicine | 3 | 2016 | 147 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2017 | 621 | 0.100 |
Why?
|
| Sphingomyelins | 1 | 2011 | 16 | 0.090 |
Why?
|
| Epilepsy | 1 | 2018 | 859 | 0.090 |
Why?
|
| Uncertainty | 1 | 2011 | 99 | 0.090 |
Why?
|
| Self Report | 1 | 2014 | 502 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 223 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2011 | 1005 | 0.090 |
Why?
|
| Alcoholism | 1 | 2013 | 229 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2014 | 519 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2013 | 3319 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2007 | 820 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 190 | 0.090 |
Why?
|
| Emigration and Immigration | 2 | 2001 | 81 | 0.090 |
Why?
|
| Body Mass Index | 5 | 2007 | 1468 | 0.090 |
Why?
|
| Surveys and Questionnaires | 7 | 2018 | 3641 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2009 | 1473 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 457 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 805 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2022 | 15927 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2009 | 448 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2013 | 3245 | 0.070 |
Why?
|
| Survival | 1 | 2006 | 19 | 0.070 |
Why?
|
| Pennsylvania | 2 | 2016 | 46 | 0.070 |
Why?
|
| Community Health Centers | 3 | 2003 | 39 | 0.070 |
Why?
|
| Anthropometry | 2 | 2004 | 189 | 0.070 |
Why?
|
| Relief Work | 1 | 2006 | 31 | 0.070 |
Why?
|
| Diuretics | 2 | 2013 | 158 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2021 | 5996 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2003 | 1300 | 0.070 |
Why?
|
| Geriatrics | 2 | 2006 | 72 | 0.060 |
Why?
|
| Counseling | 1 | 2007 | 218 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2014 | 12070 | 0.060 |
Why?
|
| Disasters | 1 | 2006 | 99 | 0.060 |
Why?
|
| Motor Activity | 2 | 2007 | 508 | 0.060 |
Why?
|
| Chi-Square Distribution | 4 | 2011 | 585 | 0.060 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 175 | 0.060 |
Why?
|
| Reaction Time | 1 | 2004 | 170 | 0.060 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 114 | 0.060 |
Why?
|
| Visual Perception | 1 | 2004 | 125 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2006 | 804 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 189 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2004 | 139 | 0.050 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2003 | 71 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 206 | 0.050 |
Why?
|
| Specialization | 1 | 2003 | 76 | 0.050 |
Why?
|
| tau Proteins | 1 | 2024 | 189 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2004 | 861 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2002 | 3083 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2003 | 75 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2001 | 1108 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2009 | 3316 | 0.050 |
Why?
|
| Medicine | 1 | 2003 | 97 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2024 | 263 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 337 | 0.050 |
Why?
|
| Family Practice | 2 | 2016 | 90 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 431 | 0.050 |
Why?
|
| Geriatric Assessment | 2 | 2000 | 168 | 0.050 |
Why?
|
| Lipids | 1 | 2004 | 512 | 0.050 |
Why?
|
| Prejudice | 1 | 2001 | 36 | 0.050 |
Why?
|
| Program Evaluation | 3 | 2016 | 446 | 0.050 |
Why?
|
| Metabolic Syndrome | 1 | 2004 | 325 | 0.050 |
Why?
|
| Learning | 1 | 2004 | 358 | 0.050 |
Why?
|
| Awareness | 1 | 2001 | 81 | 0.050 |
Why?
|
| Sampling Studies | 2 | 2001 | 74 | 0.050 |
Why?
|
| Syndrome | 1 | 2004 | 1123 | 0.050 |
Why?
|
| Incidence | 2 | 2001 | 3033 | 0.050 |
Why?
|
| Cause of Death | 1 | 2003 | 455 | 0.050 |
Why?
|
| Acute Disease | 1 | 2004 | 1092 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2001 | 135 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2001 | 121 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 1407 | 0.040 |
Why?
|
| Glycogen | 1 | 1999 | 64 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2001 | 279 | 0.040 |
Why?
|
| Postprandial Period | 1 | 1999 | 75 | 0.040 |
Why?
|
| American Heart Association | 1 | 2021 | 293 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 1151 | 0.040 |
Why?
|
| Urban Population | 2 | 1998 | 218 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 414 | 0.040 |
Why?
|
| Social Work | 1 | 1999 | 19 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2000 | 210 | 0.040 |
Why?
|
| Smoking | 1 | 2004 | 1029 | 0.040 |
Why?
|
| Hyperglycemia | 2 | 1999 | 222 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 234 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2012 | 367 | 0.040 |
Why?
|
| Triglycerides | 1 | 2001 | 560 | 0.040 |
Why?
|
| Cholesterol | 1 | 2001 | 522 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 588 | 0.040 |
Why?
|
| Social Support | 2 | 2012 | 343 | 0.040 |
Why?
|
| Age of Onset | 2 | 2011 | 581 | 0.030 |
Why?
|
| Hippocampus | 1 | 2022 | 816 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 1996 | 50 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2016 | 78 | 0.030 |
Why?
|
| Aging | 1 | 2003 | 1175 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 1066 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 238 | 0.030 |
Why?
|
| Random Allocation | 1 | 1996 | 417 | 0.030 |
Why?
|
| Urban Health | 2 | 2012 | 71 | 0.030 |
Why?
|
| Educational Status | 1 | 1996 | 268 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 1996 | 247 | 0.030 |
Why?
|
| Glucose | 1 | 1999 | 876 | 0.030 |
Why?
|
| Age Factors | 1 | 2001 | 2796 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1999 | 545 | 0.030 |
Why?
|
| Foot Diseases | 1 | 1993 | 24 | 0.030 |
Why?
|
| Protestantism | 1 | 2013 | 3 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 113 | 0.030 |
Why?
|
| Poverty | 2 | 2012 | 416 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2003 | 1158 | 0.030 |
Why?
|
| Sex Factors | 2 | 2000 | 1242 | 0.030 |
Why?
|
| Lisinopril | 1 | 2012 | 25 | 0.030 |
Why?
|
| Amlodipine | 1 | 2012 | 22 | 0.030 |
Why?
|
| Chlorthalidone | 1 | 2012 | 25 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2012 | 52 | 0.030 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2012 | 14 | 0.030 |
Why?
|
| Eye Diseases | 1 | 1993 | 113 | 0.030 |
Why?
|
| College Admission Test | 1 | 1991 | 4 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2012 | 93 | 0.020 |
Why?
|
| Depression | 1 | 2000 | 1216 | 0.020 |
Why?
|
| Diastole | 1 | 2011 | 170 | 0.020 |
Why?
|
| Korea | 1 | 2011 | 35 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 233 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 245 | 0.020 |
Why?
|
| Attitude to Health | 1 | 1992 | 256 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 387 | 0.020 |
Why?
|
| Africa | 2 | 2001 | 127 | 0.020 |
Why?
|
| Phenotype | 1 | 1999 | 4220 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1992 | 376 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1689 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2012 | 638 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1302 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cotinine | 1 | 2007 | 23 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2007 | 35 | 0.020 |
Why?
|
| Group Processes | 1 | 2007 | 47 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2007 | 79 | 0.020 |
Why?
|
| Health Facility Environment | 1 | 2006 | 8 | 0.020 |
Why?
|
| Public Health Practice | 1 | 2006 | 21 | 0.020 |
Why?
|
| Focus Groups | 1 | 2007 | 200 | 0.020 |
Why?
|
| Sodium | 1 | 2007 | 290 | 0.020 |
Why?
|
| Triage | 1 | 2006 | 140 | 0.020 |
Why?
|
| Radiology | 1 | 2006 | 103 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 997 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 2536 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2006 | 246 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 12355 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2003 | 103 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 966 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 13858 | 0.010 |
Why?
|
| Adolescent | 2 | 2018 | 19037 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2007 | 678 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 2001 | 21 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2001 | 54 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1984 | 320 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 1998 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 304 | 0.010 |
Why?
|
| Students, Medical | 1 | 1984 | 358 | 0.010 |
Why?
|
| Heart Failure | 1 | 2012 | 2125 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2000 | 277 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2000 | 119 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1999 | 272 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 2827 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 1999 | 107 | 0.010 |
Why?
|
| Lactic Acid | 1 | 1999 | 146 | 0.010 |
Why?
|
| Mandatory Reporting | 1 | 1999 | 16 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1999 | 203 | 0.010 |
Why?
|
| Child | 1 | 2018 | 24168 | 0.010 |
Why?
|
| Mexican Americans | 1 | 1999 | 198 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 1316 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 1580 | 0.010 |
Why?
|
| Pediatrics | 1 | 2006 | 1142 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2000 | 1235 | 0.010 |
Why?
|
| Reference Values | 1 | 1996 | 699 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1999 | 748 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2001 | 995 | 0.010 |
Why?
|
| Cost Savings | 1 | 1993 | 69 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6202 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1993 | 90 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 1993 | 140 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1993 | 197 | 0.010 |
Why?
|
| Health Education | 1 | 1993 | 222 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1996 | 2814 | 0.010 |
Why?
|